Covalon Technologies Ltd. (TSXV:COV)
Canada
· Delayed Price · Currency is CAD | Market Cap | 52.47M |
| Revenue (ttm) | 31.54M |
| Net Income (ttm) | 977.42K |
| Shares Out | 27.62M |
| EPS (ttm) | 0.03 |
| PE Ratio | 55.28 |
| Forward PE | 21.71 |
| Dividend | 0.15 (7.69%) |
| Ex-Dividend Date | Nov 4, 2025 |
| Volume | 3,251 |
| Average Volume | 8,417 |
| Open | 1.930 |
| Previous Close | 1.900 |
| Day's Range | 1.890 - 1.940 |
| 52-Week Range | 1.550 - 3.100 |
| Beta | -0.01 |
| RSI | 50.58 |
| Earnings Date | Feb 25, 2026 |
About Covalon Technologies
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company’s platform technologies comprises collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secon... [Read more]
Financial Performance
In fiscal year 2025, Covalon Technologies's revenue was 32.82 million, an increase of 5.29% compared to the previous year's 31.17 million. Earnings were 2.06 million, a decrease of -22.91%.
Financial StatementsNews
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (TSX: COV; OTCQX: CVALF), an advanced medical technologies company, today announced a series of important milestones reflecting the Com...
Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its upcoming presence at the Infusion Nurses Socie...
Covalon Announces Grant of Deferred Share Units
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the Company has gr...
Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the ma...
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting...
Covalon Technologies Earnings Call Transcript: Q1 2026
Q1 revenue declined year-over-year, but gross margins remained strong and Q2 is already outperforming Q1. Major new hospital wins, strong customer retention, and investments in automation and IT are driving optimism for robust growth in fiscal 2026.
Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first...
Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety an...
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2026 resul...
Covalon Technologies Earnings Call Transcript: Q4 2025
Achieved record Q4 revenue and 5% annual growth, driven by strong U.S. and international sales, despite a decline in advanced wound care due to inventory and partner issues. Maintained high gross margins, paid a special dividend, and ended the year with strong cash and no debt.
Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourt...
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fisc...
Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the payment on Novemb...
Covalon Technologies Transcript: Planet MicroCap Showcase: TORONTO 2025
The company is focused on wound care and vascular access, leveraging unique products and clinical evidence to drive growth, especially in the U.S. Recent financial strength enabled a special dividend, while ongoing investments and strategic flexibility position it for future expansion.
Covalon Declares First Ever Special Cash Dividend
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Dir...
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company improving lives through innovative wou...
Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety an...
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation in the As...
Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. Abe Schwartz...
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation at the As...
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of re...
Covalon Technologies Earnings Call Transcript: Q3 2025
Q3 saw over 10% sequential revenue growth, strong U.S. and international expansion, and robust cash generation. Adjusted gross margin improved after one-time charges, and management expects continued growth and margin stabilization into Q4 and next year.
Covalon Reports Strong Sequential Quarter on Quarter and Trailing Twelve Months Performance
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 third...
Covalon Technologies Ltd. Achieves DTC Eligibility in the United States
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that its commo...
CORRECTING and REPLACING Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--The date in the first paragraph should read: Thursday, August 21, 2025 (instead of Wednesday, August 21, 2025). The updated release reads: COVALON ANNOUNCES CONF...